AB Science S.A. (0Q77.L)
0Q77.L Stock Price Chart
Explore AB Science S.A. interactive price chart. Choose custom timeframes to analyze 0Q77.L price movements and trends.
0Q77.L Company Profile
Discover essential business fundamentals and corporate details for AB Science S.A. (0Q77.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
19 Oct 2012
Employees
40.00
Website
https://www.ab-science.comCEO
Alain Moussy MBA
Description
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company also develops AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. It markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
0Q77.L Financial Timeline
Browse a chronological timeline of AB Science S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 30 Sept 2025
Earnings released on 12 May 2025
Earnings released on 10 Oct 2024
EPS came in at -€0.09, while revenue for the quarter reached €560.00K.
Earnings released on 15 May 2024
EPS came in at -€0.03, while revenue for the quarter reached €522.00K.
Earnings released on 30 Jun 2023
EPS came in at -€0.22, while revenue for the quarter reached €448.00K.
Earnings released on 31 Dec 2022
EPS came in at -€0.14, while revenue for the quarter reached €329.00K.
Earnings released on 30 Jun 2022
EPS came in at -€0.15, while revenue for the quarter reached €629.00K.
Dividend declared on 15 Mar 2022
A dividend of €0.29 per share was announced, adjusted to €0.29.
Earnings released on 31 Dec 2021
EPS came in at -€0.21, while revenue for the quarter reached €789.00K.
Earnings released on 30 Jun 2021
EPS came in at -€0.10, while revenue for the quarter reached €818.00K.
Earnings released on 31 Dec 2020
EPS came in at -€0.14 surpassing the estimated -€0.17 by +19.96%, while revenue for the quarter reached €776.00K, missing expectations by -13.78%.
0Q77.L Stock Performance
Access detailed 0Q77.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.